Common Sensing is a Cambridge, MA based startup, founded in 2012, that is focused on developing smart health technology for individuals using disposable pen-injectors. The company's flagship product, the Gocap® System, features a smart cap for disposable pen-injectors, which automatically transmits drug-delivery data to a connected phone app. With the slogan "Smart devices with common sense," Common Sensing aims to provide accessible and innovative solutions in the Health Care, Health and Wellness, Manufacturing, and Medical Devices industries.
The startup's recent milestone includes a Private Equity Round investment in January 2021, with Pleasant Bay Capital Partners as the key investor. Common Sensing's emphasis on progressive and authentic company culture underlines its commitment to leveraging teamwork as the foundation of its operations.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Private Equity Round | Unknown | 1 | 01 Jan 2021 | |
Debt Financing | $1.43M | - | 09 Nov 2020 | |
Debt Financing | $2.00M | - | 10 Apr 2019 | |
Series A | $6.60M | 6 | Philips, Haselmeier | 11 Apr 2018 |
Debt Financing | $225.00K | - | 20 Feb 2018 |
No recent news or press coverage available for Common Sensing.